| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 6.7e-05 | 1 |